Log in to your Inderes Free account to see all free content on this page.
ODI Pharma
1 investor is following this company
ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in Europe and is headquartered in Stockholm.
ShowingAll content types
ODI Pharma AB: Publication of interim report Q3 2023/2024
Preliminary results for ODI Pharma indicate significant revenue increase in Q3 2023/2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio